Hepatitis C Drug Market Size & Share to Surpass $56.5 Billion by 2030
WASHINGTON, Aug. 17, 2023 (GLOBE NEWSWIRE) -- According to Vantage Market Research, the Global Hepatitis C Drug Market is estimated to be valued at USD 56.5 Billion by 2030 and is expected to exhibit a CAGR of 14.5% from 2023 to 2030. The global Hepatitis C Drug Market grew to USD 21.9 Billion in 2022. As per Vantage Market Research, the global Hepatitis C Drug Market has been steadily growing due to the increasing prevalence of hepatitis C infections and the introduction of innovative drugs wit